We further investigated the inhibitory effects of Psoralen on NLRP3 inflammasome activation in microglia and astrocytes, two key glial cell types that exacerbate neuroinflammation and contribute to PD progression. The gene discussed is NLRP3; the disease is Parkinson disease.